Standardized Data Structures in Rare Diseases: CDISC User Guides for Duchenne Muscular Dystrophy and Huntington's Disease
Interest in drug development for rare diseases has expanded dramatically since the Orphan Drug Act was passed in 1983, with 40% of new drug approvals in 2019 targeting orphan indications. However, limited quantitative understanding of natural history and disease progression hinders progress and incr...
Saved in:
Main Authors: | Ariana P. Mullin (Author), Diane Corey (Author), Emily C. Turner (Author), Richard Liwski (Author), Daniel Olson (Author), Jackson Burton (Author), Sudhir Sivakumaran (Author), Lynn D. Hudson (Author), Klaus Romero (Author), Diane T. Stephenson (Author), Jane Larkindale (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of a model‐based clinical trial simulation platform to optimize the design of clinical trials for Duchenne muscular dystrophy
by: Karthik Lingineni, et al.
Published: (2022) -
Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1989) -
Prednisone in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1991) -
Myocardial atrophy in children with mitochondrial disease and Duchenne muscular dystrophy
by: Tae Ho Lee, et al.
Published: (2014) -
Introduction to the CDISC standard system and its application status
by: Ze WANG, et al.
Published: (2024)